ThinkEquity Starts Regeneron Pharma (REGN) at Buy, Sets $120 Price Target
Tweet
Share
E-mailGet Alerts REGN Hot Sheet
Price: $810.24 --0%
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 9 | New: 13
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 9 | New: 13
Join SI Premium – FREE
ThinkEquity initiates coverage on shares of Regeneron Pharma (NASDAQ: REGN) with a Buy rating and $120 price target.
For an analyst ratings summary and ratings history on Regeneron Pharma click here. For more ratings news on Regeneron Pharma click here.
Shares of Regeneron Pharma closed at $95.01 yesterday.
For an analyst ratings summary and ratings history on Regeneron Pharma click here. For more ratings news on Regeneron Pharma click here.
Shares of Regeneron Pharma closed at $95.01 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wedbush Starts Aktis Oncology (AKTS) at Outperform
- BMO Capital Starts Alnylam Pharmaceuticals (ALNY) at Outperform
- Jefferies Starts Hesai (2525:HK) (HSAI) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
ThinkEquitySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
